Enzymatica AB: Enzymatica signs agreement with Qualia Pharma for Greece and Cyprus
Press releaseLund May 22, 2018 Enzymatica signs agreement with Qualia Pharma for Greece and Cyprus Enzymatica has entered into a distribution agreement with Qualia Pharma for marketing and sales of ColdZyme® Mouth Spray on the Greek and Cypriot market. The background to the agreement is that Qualia Pharma acquired Life NLB on March 1, 2018. The distribution agreement that Enzymatica previously had with Life NLB is now being transferred to Qualia Pharma. "We see a clear advantage to signing an agreement with Qualia Pharma, which is a larger market participant and can